{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:38:28Z","timestamp":1778009908404,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-111066"],"award-info":[{"award-number":["MOP-111066"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-130331"],"award-info":[{"award-number":["MOP-130331"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jpsychires.2021.12.049","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T16:07:02Z","timestamp":1640189222000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia"],"prefix":"10.1016","volume":"146","author":[{"given":"James N.","family":"Tsoporis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin M.","family":"Ektesabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehla","family":"Izhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Salpeas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis K.","family":"Rizos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3550-9814","authenticated-orcid":false,"given":"Stylianos P.","family":"Kympouropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-0825","authenticated-orcid":false,"given":"Emmanouil","family":"Rizos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2021.12.049_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-981-10-6583-5_3","article-title":"Expression of DJ-1 in neurodegenerative disorders","volume":"1037","author":"Antipova","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib2","first-page":"1590","article-title":"Potential role of exosome in post-stroke reorganization and\/or neurodegeneration","volume":"19","author":"Azizi","year":"2020","journal-title":"EXCLI J"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12031-018-1165-4","article-title":"Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia","volume":"66","author":"Bai","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2017.08.005","article-title":"Recent findings on the physiological function of DJ-1: beyond Parkinson's disease","volume":"108","author":"Biosa","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib6","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1017\/S0033291719001685","article-title":"Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis","volume":"49","author":"Bora","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib8","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1073\/pnas.0607260103","article-title":"DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2","volume":"103","author":"Clements","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.14348\/molcells.2016.0118","article-title":"MicroRNA-203 as a stemness inhibitor of glioblastoma stem cells","volume":"39","author":"Deng","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2147\/NDT.S60034","article-title":"Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia","volume":"10","author":"Dietrich-Muszalska","year":"2014","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib11","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib12","series-title":"Structured Clinical Interview for DSM-IV axis II Personality Disorders, (SCID-II)","author":"First","year":"1997"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/schbul\/sby125","article-title":"Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis","volume":"45","author":"Fraguas","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.physbeh.2007.05.046","article-title":"DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents","volume":"92","author":"Galter","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0920-9964(02)00405-X","article-title":"Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia","volume":"62","author":"Grima","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ddr.21277","article-title":"Berman NE, Sandhir R. Targeting MicroRNAs in prevention and treatment of neurodegenerative disorders","volume":"76","author":"Gupta","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41065-017-0044-2","article-title":"MiRNAs of peripheral blood as the biomarker of schizophrenia","volume":"155","author":"He","year":"2017","journal-title":"Hereditas"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00406-016-0749-7","article-title":"Oxidative stress in drug-naive first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders","volume":"268","author":"Jordan","year":"2018","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib20","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2009.08.003","article-title":"DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders","volume":"47","author":"Kahle","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2004.03.110","article-title":"Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells","volume":"317","author":"Kinumi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00414-011-0578-1","article-title":"Fracasso T, Vennemann M. RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays","volume":"125","author":"Koppelkamm","year":"2011","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41380-018-0104-7","article-title":"Glutathione and glutamate in schizophrenia: a 7T MRS study","volume":"25","author":"Kumar","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1176\/appi.ajp.2019.19080865","article-title":"Early detection and preventive intervention in schizophrenia: from fantasy to reality","volume":"176","author":"Lieberman","year":"2019","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib26","doi-asserted-by":"crossref","first-page":"14582","DOI":"10.1038\/s41598-021-93671-1","article-title":"Immunomodulatory role of Parkinson's disease 7 in inflammatory bowel disease","volume":"11","author":"Lippai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib27","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1038\/tp.2017.138","article-title":"Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia","volume":"7","author":"Maas","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2010.05.088","article-title":"Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics","volume":"479","author":"Padurariu","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-981-10-6583-5_6","article-title":"The multifaceted roles of DJ-1 as an antioxidant","volume":"1037","author":"Raninga","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib31","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/jcm8091377","article-title":"DJ-1 in Parkinson's disease: clinical insights and therapeutic perspectives","volume":"8","author":"Repici","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001874","article-title":"Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation","volume":"12","author":"Ridder","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib34","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib35","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.3892\/mmr.2016.5853","article-title":"miRNAs and their role in the correlation between schizophrenia and cancer","volume":"14","author":"Rizos","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.psychres.2012.07.024","article-title":"Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study","volume":"200","author":"Ruiz-Litago","year":"2012","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/HRP.0000000000000090","article-title":"DSM-5 and mental disorders in older individuals: an overview","volume":"23","author":"Sachdev","year":"2015","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.psychres.2013.09.014","article-title":"Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia","volume":"210","author":"Samuelsson","year":"2013","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2016.06.014","article-title":"Oxidative stress and inflammation in schizophrenia","volume":"176","author":"Sawa","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1126\/science.1070532","article-title":"Schizophrenia: diverse approaches to a complex disease","volume":"296","author":"Sawa","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4172\/2161-0460.1000420","article-title":"microRNAs in neurodegeneration: current findings and potential impacts","volume":"8","author":"Sharma","year":"2018","journal-title":"J. Alzheimers Dis. Parkinson."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.biopsych.2012.03.025","article-title":"N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia","volume":"71","author":"Shungu","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.b.30272","article-title":"Evaluating the comparability of gene expression in blood and brain","volume":"141B","author":"Sullivan","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-018-0223-3","article-title":"Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia","volume":"25","author":"Swarup","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib47","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/molecules26133795","article-title":"Cytoprotective mechanisms of DJ-1: implications in cardiac pathophysiology","volume":"26","author":"Tsoporis","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib48","doi-asserted-by":"crossref","first-page":"101732","DOI":"10.1016\/j.pneurobio.2019.101732","article-title":"Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders","volume":"185","author":"van den Berg","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib50","article-title":"Screening of schizophrenia associated miRNAs and the regulation of miR-320a-3p on integrin beta1","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jpsychires.2021.12.049_bib51","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.2010.06658.x","article-title":"DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity","volume":"113","author":"Yamashita","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/neu.2019.29","article-title":"Brain glutathione levels and age at onset of illness in chronic schizophrenia","volume":"31","author":"Yang","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib53","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1021\/ja910275u","article-title":"Deiters A Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma","volume":"132","author":"Young","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S1092852917000803","article-title":"Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study","volume":"24","author":"Zeni-Graiff","year":"2012","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2021.12.049_bib55","doi-asserted-by":"crossref","first-page":"113190","DOI":"10.1016\/j.physbeh.2020.113190","article-title":"Chan H, Ding Y, Cu G. Inhibition of microRNA-203 protects against traumatic brain injury induced neural damages via suppressing neuronal apoptosis and dementia-related molecules","volume":"228","author":"Zhao","year":"2021","journal-title":"Physiol. Behav."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621007524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621007524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:24:10Z","timestamp":1758367450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395621007524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"alternative-id":["S0022395621007524"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.12.049","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.12.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}